Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Eton Pharmaceuticals, Inc. (ETON)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
22 Sep 2022
BRYNJELSEN SEAN
Chief Executive Officer, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,040,000
+0%
10,000
$2.10
$21,042.00
SELL
17 Nov 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,375,000
-1%
25,000
$4.67
$116,712.50
SELL
15 Nov 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,400,000
-0%
15,438
$4.85
$74,877.11
SELL
5 Nov 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,414,000
-8%
220,362
$6.25
$1,377,985.50
SELL
3 Nov 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,623,300
-7%
202,200
$6.49
$1,312,500.80
SELL
8 Oct 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,815,000
-5%
165,100
$5.03
$830,670.50
BUY
20 Aug 2021
BRYNJELSEN SEAN
President & CEO, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,030,000
+0%
10,000
$4.32
$43,200.00
BUY
20 Aug 2021
Troutman William Wilson
CFO, Treasurer & Secretary, Officer
Eton Pharmaceuticals, Inc.
(ETON)
23,027
+27%
5,000
$4.43
$22,150.00
SELL
4 Aug 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
2,971,100
-16%
604,500
$5.83
$3,523,187.20
BUY
3 Jun 2021
BRYNJELSEN SEAN
President & CEO, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,030,000
+0%
5,000
$5.96
$29,800.00
SELL
26 May 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
3,551,100
-2%
105,000
$8.07
$847,350.00
SELL
25 May 2021
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
3,652,100
-6%
242,300
$8.52
$2,064,511.00
SELL
12 Apr 2021
HARROW HEALTH, INC.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
1,982,000
-43%
1,518,000
$7.00
$10,626,000.00
BUY
16 Oct 2020
Opaleye Management Inc.
10% Owner
Eton Pharmaceuticals, Inc.
(ETON)
3,885,000
+11%
400,000
$7.00
$2,800,000.00
BUY
13 Aug 2019
BRYNJELSEN SEAN
President & CEO, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,025,000
+0%
5,000
$6.15
$30,750.00
BUY
9 Aug 2019
CASAMENTO CHARLES J
Director
Eton Pharmaceuticals, Inc.
(ETON)
71,920
+5%
3,500
$6.11
$21,369.95
BUY
20 May 2019
BRYNJELSEN SEAN
President & CEO, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,020,000
+0%
10,000
$7.93
$79,325.86
BUY
15 Nov 2018
BRYNJELSEN SEAN
President & CEO, Director, Officer
Eton Pharmaceuticals, Inc.
(ETON)
1,010,000
+1%
10,000
$6.00
$60,000.00
BUY
15 Nov 2018
CASAMENTO CHARLES J
Director
Eton Pharmaceuticals, Inc.
(ETON)
68,420
+7%
5,000
$6.00
$30,000.00
BUY
15 Nov 2018
Troutman William Wilson
CFO, Treasurer & Secretary, Officer
Eton Pharmaceuticals, Inc.
(ETON)
5,000
+100%
5,000
$6.00
$30,000.00
BUY
15 Nov 2018
MAIER PAUL V
Director
Eton Pharmaceuticals, Inc.
(ETON)
59,745
+9%
5,000
$6.00
$30,000.00
BUY
15 Nov 2018
BAUM MARK L
Director
Eton Pharmaceuticals, Inc.
(ETON)
10,000
+100%
10,000
$6.00
$60,000.00
BUY
15 Nov 2018
RIEDEL NORBERT G
Director
Eton Pharmaceuticals, Inc.
(ETON)
59,745
+9%
5,000
$6.00
$30,000.00
Home